{"entity":{"type":"insider","cik":"0001767215","url":"/insider/0001767215","json_url":"/insider/0001767215.json","name":"LaPlume Joseph W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":107,"n_filings":26,"first":"2019-03-12","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"LaPlume Joseph W","source":"filing","n_filings":26,"first_seen":"2019-03-12","last_seen":"2026-03-04"}],"transactions":[{"id":5956448,"accession":"0001100682-26-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001100682-26-000024","line_url":"/filing/0001100682-26-000024#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25.0,"shares_display":"25","price_per_share":174.54,"price_display":"174.54","price_state":"stated","total_value":4363.5,"total_display":"4,363.50","total_whole":"4,364","shares_owned_after":27448.0,"shares_owned_after_display":"27,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5818548,"accession":"0001100682-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001100682-26-000002","line_url":"/filing/0001100682-26-000002#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":163.72,"price_display":"163.72","price_state":"stated","total_value":65488.0,"total_display":"65,488.00","total_whole":"65,488","shares_owned_after":23716.0,"shares_owned_after_display":"23,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2026-01-20","scope":"insider"},{"id":4850118,"accession":"0001100682-25-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001100682-25-000036","line_url":"/filing/0001100682-25-000036#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":157.6,"price_display":"157.60","price_state":"stated","total_value":126080.0,"total_display":"126,080.00","total_whole":"126,080","shares_owned_after":24116.0,"shares_owned_after_display":"24,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4753666,"accession":"0001127602-25-020282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-020282","line_url":"/filing/0001127602-25-020282#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":150.04,"price_display":"150.04","price_state":"stated","total_value":60016.0,"total_display":"60,016.00","total_whole":"60,016","shares_owned_after":24916.0,"shares_owned_after_display":"24,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-08-08","scope":"insider"},{"id":5211542,"accession":"0001127602-25-014484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-014484","line_url":"/filing/0001127602-25-014484#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":145.41,"price_display":"145.41","price_state":"stated","total_value":72705.0,"total_display":"72,705.00","total_whole":"72,705","shares_owned_after":19513.0,"shares_owned_after_display":"19,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-15","scope":"insider"},{"id":4801561,"accession":"0001127602-25-006249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-006249","line_url":"/filing/0001127602-25-006249#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":162.5,"price_display":"162.50","price_state":"stated","total_value":715000.0,"total_display":"715,000.00","total_whole":"715,000","shares_owned_after":20013.0,"shares_owned_after_display":"20,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":2421855,"accession":"0001127602-24-022003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-022003","line_url":"/filing/0001127602-24-022003#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":199.36,"price_display":"199.36","price_state":"stated","total_value":354860.8,"total_display":"354,860.80","total_whole":"354,861","shares_owned_after":22521.0,"shares_owned_after_display":"22,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-12","scope":"insider"},{"id":3121420,"accession":"0001127602-24-015276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-015276","line_url":"/filing/0001127602-24-015276#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":226.97,"price_display":"226.97","price_state":"stated","total_value":295968.88,"total_display":"295,968.88","total_whole":"295,969","shares_owned_after":23276.0,"shares_owned_after_display":"23,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-14","scope":"insider"},{"id":2052584,"accession":"0001127602-24-005818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-005818","line_url":"/filing/0001127602-24-005818#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":838.0,"shares_display":"838","price_per_share":238.93,"price_display":"238.93","price_state":"stated","total_value":200223.34,"total_display":"200,223.34","total_whole":"200,223","shares_owned_after":24620.0,"shares_owned_after_display":"24,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":8413814,"accession":"0001127602-23-028591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-028591","line_url":"/filing/0001127602-23-028591#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1850.0,"shares_display":"1,850","price_per_share":197.73,"price_display":"197.73","price_state":"stated","total_value":365800.5,"total_display":"365,800.50","total_whole":"365,801","shares_owned_after":23133.0,"shares_owned_after_display":"23,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":8293693,"accession":"0001127602-23-027226","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-027226","line_url":"/filing/0001127602-23-027226","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9128.0,"shares_display":"9,128","price_per_share":173.47963737949166,"price_display":"173.48","price_state":"stated","total_value":1583522.13,"total_display":"1,583,522.13","total_whole":"1,583,522","shares_owned_after":24983.0,"shares_owned_after_display":"24,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-13","scope":"insider","n_lines":2},{"id":7893892,"accession":"0001127602-23-022480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022480","line_url":"/filing/0001127602-23-022480#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":216.52,"price_display":"216.52","price_state":"stated","total_value":151564.0,"total_display":"151,564.00","total_whole":"151,564","shares_owned_after":24983.0,"shares_owned_after_display":"24,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":8675179,"accession":"0001127602-23-015694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-015694","line_url":"/filing/0001127602-23-015694#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":190.39,"price_display":"190.39","price_state":"stated","total_value":65684.55,"total_display":"65,684.55","total_whole":"65,685","shares_owned_after":24026.0,"shares_owned_after_display":"24,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":8603456,"accession":"0001127602-23-015525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-015525","line_url":"/filing/0001127602-23-015525","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":959.0,"shares_display":"959","price_per_share":193.02985401459853,"price_display":"193.03","price_state":"stated","total_value":185115.63,"total_display":"185,115.63","total_whole":"185,116","shares_owned_after":24380.0,"shares_owned_after_display":"24,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-15","scope":"insider","n_lines":2},{"id":6444671,"accession":"0001127602-22-026898","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-026898","line_url":"/filing/0001127602-22-026898","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6409.0,"shares_display":"6,409","price_per_share":224.24790212201592,"price_display":"224.25","price_state":"stated","total_value":1437204.8047,"total_display":"1,437,204.80","total_whole":"1,437,205","shares_owned_after":21338.0,"shares_owned_after_display":"21,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider","n_lines":3},{"id":6858992,"accession":"0001127602-22-025053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-025053","line_url":"/filing/0001127602-22-025053#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":534.0,"shares_display":"534","price_per_share":216.36,"price_display":"216.36","price_state":"stated","total_value":115536.24,"total_display":"115,536.24","total_whole":"115,536","shares_owned_after":20232.0,"shares_owned_after_display":"20,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-07","scope":"insider"},{"id":6217454,"accession":"0001127602-22-020666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020666","line_url":"/filing/0001127602-22-020666#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":226.1341,"price_display":"226.13","price_state":"stated","total_value":45226.82,"total_display":"45,226.82","total_whole":"45,227","shares_owned_after":20766.0,"shares_owned_after_display":"20,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":6962403,"accession":"0001127602-22-006657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006657","line_url":"/filing/0001127602-22-006657#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":395.0,"shares_display":"395","price_per_share":292.75,"price_display":"292.75","price_state":"stated","total_value":115636.25,"total_display":"115,636.25","total_whole":"115,636","shares_owned_after":19852.0,"shares_owned_after_display":"19,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-24","scope":"insider"},{"id":6746676,"accession":"0001127602-22-006343","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-22-006343","line_url":"/filing/0001127602-22-006343","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":396.0,"shares_display":"396","price_per_share":290.8337575757576,"price_display":"290.83","price_state":"stated","total_value":115170.168,"total_display":"115,170.17","total_whole":"115,170","shares_owned_after":20562.0,"shares_owned_after_display":"20,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider","n_lines":2},{"id":6746667,"accession":"0001127602-22-006343","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-006343","line_url":"/filing/0001127602-22-006343#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1143.0,"shares_display":"1,143","price_per_share":291.8,"price_display":"291.80","price_state":"stated","total_value":333527.4,"total_display":"333,527.40","total_whole":"333,527","shares_owned_after":21275.0,"shares_owned_after_display":"21,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":5450190,"accession":"0001127602-21-023433","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-023433","line_url":"/filing/0001127602-21-023433","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":402.20951135135135,"price_display":"402.21","price_state":"stated","total_value":1488175.192,"total_display":"1,488,175.19","total_whole":"1,488,175","shares_owned_after":10704.0,"shares_owned_after_display":"10,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider","n_lines":4},{"id":4410874,"accession":"0001127602-21-008123","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-21-008123","line_url":"/filing/0001127602-21-008123","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8735.0,"shares_display":"8,735","price_per_share":281.69604933028046,"price_display":"281.70","price_state":"stated","total_value":2460614.9909,"total_display":"2,460,614.99","total_whole":"2,460,615","shares_owned_after":13650.0,"shares_owned_after_display":"13,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-26","scope":"insider","n_lines":4},{"id":3011835,"accession":"0001127602-20-028214","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-20-028214","line_url":"/filing/0001127602-20-028214","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6739.0,"shares_display":"6,739","price_per_share":250.27856852648762,"price_display":"250.28","price_state":"stated","total_value":1686627.2733,"total_display":"1,686,627.27","total_whole":"1,686,627","shares_owned_after":11356.0,"shares_owned_after_display":"11,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-05","scope":"insider","n_lines":3},{"id":3045895,"accession":"0001127602-20-017158","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-20-017158","line_url":"/filing/0001127602-20-017158#line-5","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":174.6511,"price_display":"174.65","price_state":"stated","total_value":61127.885,"total_display":"61,127.88","total_whole":"61,128","shares_owned_after":9637.0,"shares_owned_after_display":"9,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-19","scope":"insider"},{"id":3045893,"accession":"0001127602-20-017158","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-017158","line_url":"/filing/0001127602-20-017158","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15418.0,"shares_display":"15,418","price_per_share":168.2559317615774,"price_display":"168.26","price_state":"stated","total_value":2594169.9559,"total_display":"2,594,169.96","total_whole":"2,594,170","shares_owned_after":14886.0,"shares_owned_after_display":"14,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider","n_lines":2},{"id":8732945,"accession":"0001127602-19-010921","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-30","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":138.08,"price_display":"138.08","price_state":"stated","total_value":82848.0,"total_display":"82,848.00","total_whole":"82,848","shares_owned_after":16372.0,"shares_owned_after_display":"16,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732941,"accession":"0001127602-19-010921","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-29","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":507.0,"shares_display":"507","price_per_share":138.15,"price_display":"138.15","price_state":"stated","total_value":70042.05,"total_display":"70,042.05","total_whole":"70,042","shares_owned_after":15458.0,"shares_owned_after_display":"15,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732936,"accession":"0001127602-19-010921","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-28","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":138.07,"price_display":"138.07","price_state":"stated","total_value":41421.0,"total_display":"41,421.00","total_whole":"41,421","shares_owned_after":16972.0,"shares_owned_after_display":"16,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732932,"accession":"0001127602-19-010921","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-27","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":138.03,"price_display":"138.03","price_state":"stated","total_value":41409.0,"total_display":"41,409.00","total_whole":"41,409","shares_owned_after":17780.0,"shares_owned_after_display":"17,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732928,"accession":"0001127602-19-010921","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-26","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":138.02,"price_display":"138.02","price_state":"stated","total_value":41406.0,"total_display":"41,406.00","total_whole":"41,406","shares_owned_after":18110.0,"shares_owned_after_display":"18,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732923,"accession":"0001127602-19-010921","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-25","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":137.9,"price_display":"137.90","price_state":"stated","total_value":41370.0,"total_display":"41,370.00","total_whole":"41,370","shares_owned_after":19550.0,"shares_owned_after_display":"19,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732918,"accession":"0001127602-19-010921","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-24","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":137.87,"price_display":"137.87","price_state":"stated","total_value":41361.0,"total_display":"41,361.00","total_whole":"41,361","shares_owned_after":20050.0,"shares_owned_after_display":"20,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732915,"accession":"0001127602-19-010921","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-23","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":137.91,"price_display":"137.91","price_state":"stated","total_value":41235.09,"total_display":"41,235.09","total_whole":"41,235","shares_owned_after":19251.0,"shares_owned_after_display":"19,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732910,"accession":"0001127602-19-010921","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-22","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":138.06,"price_display":"138.06","price_state":"stated","total_value":33134.4,"total_display":"33,134.40","total_whole":"33,134","shares_owned_after":17272.0,"shares_owned_after_display":"17,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732905,"accession":"0001127602-19-010921","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-21","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230.0,"shares_display":"230","price_per_share":137.99,"price_display":"137.99","price_state":"stated","total_value":31737.7,"total_display":"31,737.70","total_whole":"31,738","shares_owned_after":18526.0,"shares_owned_after_display":"18,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"},{"id":8732900,"accession":"0001127602-19-010921","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001127602-19-010921","line_url":"/filing/0001127602-19-010921#line-20","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001767215","owner_name":"LaPlume Joseph W","owner_display_name":"LaPlume Joseph W","owner_url":"/insider/0001767215","role":"Officer (EVP, Corp Strategy & Develop)","role_mark":"O","role_mark_label":"Officer (EVP, Corp Strategy & Develop)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp Strategy & Develop","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":138.17,"price_display":"138.17","price_state":"stated","total_value":27634.0,"total_display":"27,634.00","total_whole":"27,634","shares_owned_after":15079.0,"shares_owned_after_display":"15,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-12","scope":"insider"}],"collapsed":true,"next_cursor":"2019-03-08|8732900","ledger_fault":false,"count":{"value":107,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":106,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":107},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","url":"/issuer/0001100682","role":"Officer (EVP, Corp Strategy & Develop)","n_filings":26,"first_seen":"2019-03-12","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767215","retrieved_at":"2026-08-23T20:04:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}